Genetic diversity of heat-labile toxin expressed by enterotoxigenic Escherichia coli strains isolated from humans by Lasaro, M. A. et al.
JOURNAL OF BACTERIOLOGY, Apr. 2008, p. 2400–2410 Vol. 190, No. 7
0021-9193/08/$08.000 doi:10.1128/JB.00988-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Genetic Diversity of Heat-Labile Toxin Expressed by Enterotoxigenic
Escherichia coli Strains Isolated from Humans
M. A. Lasaro,1† J. F. Rodrigues,1 C. Mathias-Santos,1 B. E. C. Guth,2 A. Balan,1
M. E. Sbrogio-Almeida,3 and L. C. S. Ferreira1*
Department of Microbiology, Institute of Biomedical Sciences, University of Sa˜o Paulo, Sa˜o Paulo, Brazil1; Department of
Microbiology, Immunology and Parasitology, Federal University of Sa˜o Paulo, Sa˜o Paulo, Brazil2; and Division of
Technological Development, Butantan Institute, Sa˜o Paulo, Brazil3
Received 21 June 2007/Accepted 8 January 2008
The natural diversity of the elt operons, encoding the heat-labile toxin LT-I (LT), carried by enterotoxigenic
Escherichia coli (ETEC) strains isolated from humans was investigated. For many years, LT was supposed to
be represented by a rather conserved toxin, and one derivative, produced by the reference H10407 strain, was
intensively studied either as a virulence factor or as a vaccine adjuvant. Amplicons encompassing the two
LT-encoding genes (eltA and eltB) of 51 human-derived ETEC strains, either LT (25 strains) only or LT/ST
(26 strains), isolated from asymptomatic (24 strains) or diarrheic (27 strains) subjects, were subjected to
restriction fragment length polymorphism (RFLP) analysis and DNA sequencing. Seven polymorphic RFLP
types of the H10407 strain were detected with six (BsaI, DdeI, HhaI, HincII, HphI, and MspI) restriction
enzymes. Additionally, the single-nucleotide polymorphic analysis revealed 50 base changes in the elt operon,
including 21 polymorphic sites at eltA and 9 at eltB. Based on the deduced amino acid sequences, 16 LT types
were identified, including LT1, expressed by the H10407 strain and 23 other strains belonging to seven different
serotypes, and LT2, expressed by 11 strains of six different serotypes. In vitro experiments carried out with
purified toxins indicated that no significant differences in GM1-binding affinity could be detected among LT1,
LT2, and LT4. However, LT4, but not other toxin types, showed reduced toxic activities measured either in vitro
with cultured cells (Y-1 cells) or in vivo in rabbit ligated ileal loops. Collectively, these results indicate that the
natural diversity of LTs produced by wild-type ETEC strains isolated from human hosts is considerably larger
than previously assumed and may impact the pathogeneses of the strains and the epidemiology of the disease.
Enterotoxigenic Escherichia coli (ETEC)-associated diar-
rhea represents a major cause of mortality and morbidity
among children and travelers, respectively, in most developing
countries in Latin America, Africa, and Asia (3, 33). ETEC
secretory diarrhea involves a rather straightforward pathogen-
esis plan, requiring first colonization of small intestine epithe-
lial cells by means of filamentous adhesins collectively known
as colonization factors (CFs) and, at a second stage, produc-
tion of at least one out of two enterotoxin types, the heat-stable
toxin (ST) and/or the heat-labile toxin (LT) (28, 36). One of
the most complex aspects of ETEC pathogenesis is the remark-
able antigen heterogeneity. At least 150 O:H serotypes have
been found among ETEC strains isolated from humans, al-
though a more restricted number of serotype combinations is
detected among strains isolated from patients requiring med-
ical intervention, also characterized, in some cases, by a con-
served set of virulence-associated factors and a common clonal
origin (29, 30, 46). Moreover, the ETEC phenotypic heteroge-
neity is also well illustrated by the encoded virulence-associ-
ated factors, including more than 20 known CFs and produc-
tion of LT, ST, or both enterotoxins (10, 33, 46).
Two types of ST, STa and STb (also known as ST-I and
ST-II), have been differentiated based on biological and chem-
ical features (7, 11). Similarly, LTs produced by ETEC strains
are also a heterogeneous group of toxins. Two major LT fam-
ilies have been identified, LT-I and LT-II. LT-II is rarely found
among human-derived ETEC strains, but two natural variants
have been reported, LT-IIa and LT-IIb, based on differences in
the subunit sequences (14, 16). LT-I shows a rather high sim-
ilarity with cholera toxin (CT) (over 80% amino acid identity),
and both have been intensively studied as virulence factors and
modulators of immune responses in mammalian species, in-
cluding humans (18, 28).
The known natural variability of LT-I toxins expressed by
ETEC strains has been mainly restricted to the differences
detected between LTs produced by human (LTh)- and pig
(LTp)-derived strains. Initial evidence based on the antigenic-
ities and electrophoretic mobilities of LTh and LTp indicated
that the toxins differ in their primary amino acid sequences (19,
42). Sequencing of the elt operons encoding LTh and LTp
revealed differences in the primary sequences of the toxins,
which share over 95% identity along the complete amino acid
sequence (45). Altogether, six amino acid replacements were
detected between the A subunits (K4R, K213E, and N238D)
and the B subunits (S4T, A46E, and E102K) of LTh and LTp
derived from the H10407 and EWD299 strains, respectively
(25, 48, 50). At a time when DNA sequencing was not available
to most laboratories, application of restriction fragment length
polymorphism (RFLP) typing to a larger number of strains
showed that a single HhaI restriction site was not detected in
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the elt operon derived from pig-derived ETEC strains, thus
easily discriminating LTh and LTp (5, 45). In the case of an elt
operon from a chicken-derived ETEC strain, no difference
from the reference human-derived H10407 strain was found
(21).
LTs produced by human-derived ETEC strains apparently
have reduced natural diversity, probably reflecting the limited
number of fully sequenced elt operons. So far, the LT se-
quences produced by two human-derived ETEC strains (H74-
114 and H10407) have been determined (17, 25). Based on the
nucleotide sequences of the elt operons present in these two
strains, five polymorphic sites have been detected, leading to
four amino acid replacements: three in the A subunit (K212R,
E213K, and D238N) and one in the B subunit (H13R). More
recently, one LT variant with five polymorphic sites in the A
subunit and one in the B subunit was reported to be encoded
by a chromosomally integrated elt operon of a strain recovered
from a Japanese tourist (20). Thus, a better knowledge of LT
diversity among ETEC strains isolated from humans awaits a
more detailed scrutiny of elt operons carried by strains belong-
ing to different clonal groups or with different geographic or-
igins.
In the present study, we searched for the natural genetic
diversity of LTs expressed by 51 ETEC strains isolated from
humans, mostly children living in three major cities in Brazil.
The screened strain set included 25 strains producing LT only
and 26 LT/ST-producing (LT/ST) strains recovered from
asymptomatic (24 strains) or diarrheic (27 strains) subjects.
Our results, based on RFLP and single-nucleotide polymor-
phism analyses, revealed that LTs produced by human-derived
ETEC strains, particularly among strains producing LT only,
show significant genetic diversity, and 16 LT types have been
identified. The finding of rather large natural diversity among
LTs produced by ETEC strains may have significant impacts
on studies of both ETEC pathogenesis and the epidemiology
of the disease.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The 51 tested LT-producing ETEC
strains were derived from case-control studies of acute endemic childhood diar-
rhea in Brazil in children under the age of 5 in the cities of Sa˜o Paulo, Rio de
Janeiro, and Recife (12, 15, 34, 35) (Table 1). Twenty-four ETEC strains were
isolated from asymptomatic children, including 20 strains producing LT only and
4 LT/ST strains. Twenty-seven ETEC strains were isolated from diarrheic
subjects requiring medical assistance, including 5 strains producing LT only and
22 LT/ST strains. The reference LT/ST ETEC H10407 strain was isolated
from a patient with severe cholera-like disease in Bangladesh (9). The 258909-3
(O128:H) strain was also isolated in Bangladesh from a symptomatic case (13),
and both strains were kindly supplied by Ann Mari Svennerholm (Go¨teborg
University, Go¨teborg, Sweden). Table 1 lists all tested ETEC strains and the
respective clinical features, serotypes, toxigenic profiles, and geographic origins.
Cultures were routinely prepared in CAYE medium (2% Casamino Acids, 0.6%
yeast extract, 43 mM NaCl, 38 mM K2HPO4, and 0.1% trace salt solution
consisting of 203 mM MgSO4, 25 mM MnCl2, and 18 mM FeCl3) (20) and
incubated for 18 h at 37°C with vigorous agitation (200 rpm in a rotary shaker).
RFLP analysis of the elt operon. The presence of the elt operon carried by the
ETEC strains was initially confirmed by colony blot assays under previously
reported experimental conditions (27). Total DNA of the tested ETEC strains
was isolated according the method described by Llop and colleagues (26). Am-
plification of the elt operon was carried out with specific primers complementary
to the sequence available at GenBank (GI 408994) (50). LTI-A1 (5-AAACAA
AACAAGTGGCG) and LTI-B2 (5-GTTGTTATATAGGTTCCTAGC) prim-
ers (annealing at positions 65 to 49 and at positions 1172 to 1192 of the elt
operon, respectively) were employed for the specific amplification of a 1,257-bp
amplicon containing the complete elt operon. Amplification reactions were per-
formed in a total volume of 50 l containing 1 mM deoxynucleoside triphos-
phates, 10 pmol of each primer, 2 mM MgCl2, 5 l of 10-fold-concentrated
polymerase synthesis buffer, and 1 U of Platinum Taq DNA Polymerase High
Fidelity (Invitrogen). After an initial denaturation step of 4 min at 94°C, the
samples were subjected to 30 cycles of denaturation (94°C; 45 s), annealing
(51.7°C; 90 s), and extension (72°C; 60 s), followed by a single final extension step
of 5 min at 72°C. The PCR products were analyzed on a 0.8% agarose gel and
visualized by staining them with ethidium bromide.
DNA sequence analysis of the elt operon. The complete DNA sequences of the
elt operons carried by the tested ETEC strains were determined in an ABI 3100
(Perkin-Elmer Applied Biosystems) automated capillary DNA sequencer with
reagents of the BigDye terminator DNA Sequencing 2 (Perkin-Elmer Applied
Biosystems, Warrington, England). The sequencing reactions were performed
with seven specific primers annealing at different positions in the elt amplicon:
LTI-A2 (5-CGAGGCATACGTGTATCT), LT-A2.2A (5-CTGCCTCTTAAC
TTTTGATTG), LTI-A2.2B (5-GTTCTGTAATAGACTGGGGAGC), LTI-
B1.2A (5-GGTGATACTTGTAATGAGG), and LTI-B1.2B (5-GACTATCA
GTCAGA GGTTG) and the two primers (LTI-A1 and LTI-B2) used in the
amplification of the elt operon. The recovered DNA sequences were edited and
assembled in a single continuous sequence using the Lasergene program
(DNAStar Inc., Madison, WI). The sequencing of the elt operon amplified from
each ETEC strain was repeated at least twice to ensure the accuracy of the final
results. The locations of the detected polymorphic amino acid residues on the LT
structural model, available at the Protein Data Bank (PDB) (code 1LTS), were
generated with the Pymol program (http://www.pymol.org). The amino acid
sequence relationships of the detected LT variants (AB subunits) were repre-
sented by an unrooted tree generated with the PHYLIP program based on
neighbor-joining methods. The amino acid sequence alignments were carried out
with the ClustalW program, and the tree was visualized using the Treeview
program.
RAPD-PCR analysis. Randomly amplified polymorphic DNA (RAPD)-PCR
analyses were carried out with the arbitrary 10-mer primer 1254 (5-CCGCAG
CCAA). Template preparation and PCR amplification with primer 1254 were
performed as described previously (31). The reproducibility of the banding
patterns was checked at least twice using different DNA preparations. The
reaction products were analyzed in 1.2% agarose gels stained with ethidium
bromide. RAPD-PCR profiles were inspected visually and defined according to
the presence or absence and intensities of polymorphic bands. A 100-bp DNA
ladder (Invitrogen) was used as a molecular-size marker.
Purification of recombinant LTs. A recombinant E. coli DH5 strain harbor-
ing the pBSPKS() vector (38) carrying the complete elt operon of the H10407
strain under the control of the native promoter was used for the expression of the
LT1 type. Similarly, the genes encoding the LT2 and LT4 types from strains
25A-1 and 1372-1, respectively, were cloned into PstI and KpnI sites of the
pBSPKS() vector under the control of their native promoters. The toxins were
purified by affinity chromatography on immobilized D-galactose columns
(Pierce), as previously described (24). The purified toxins were monitored in
sodium dodecyl sulfate-containing 15% polyacrylamide gels, and the protein
concentration was determined by the Bradford assay (Bio-Rad Laboratories)
with bovine serum albumin (Sigma-Aldrich) as a standard. The proportions of
the A and B subunits of different purified LT variants were evaluated in Coo-
massie blue-stained polyacrylamide gels in which equal toxin amounts (1.5 g/
lane), boiled or not for 5 min, were loaded.
Competitive GM1-binding assay. The affinities of purified LT variants for
GM1 were evaluated by competitive enzyme-linked immunosorbent assay
(ELISA) using biotinylated cholera toxin B subunit as an inhibitor reagent
(Sigma-Aldrich), according to the method of Ba¨ckstro¨m and coworkers (1).
Briefly, wells of a polystyrene 96-well microtiter plate (Nalge Nunc) were coated
with phosphate-buffered saline (PBS)-diluted GM1 ganglioside (0.05 g ml1;
Sigma-Aldrich) and incubated overnight at room temperature. The following
day, the plates were washed and then blocked with 0.1% bovine serum albumin
(BSA) in PBS (PBS-BSA) for 30 min at 37°C. After the plates were washed with
PBS, each purified LT was diluted to 4 g ml1 in 200 l of PBS-BSA in
duplicate wells and twofold serially diluted. Peroxidase-labeled cholera toxin B
subunit at 0.2 g ml1 in 50 l was added to each well and incubated for 1 h at
room temperature. Then, color reactions were developed with -phenylenedi-
amine and H2O2. After 20 min at room temperature, the reactions were inter-
rupted by the addition of 2 M H2SO4 (50 l/well), and the A492 was measured in
a microplate reader (Multiskan EX; ThermoLabsystems). CT (Calbiochem) was
used as a positive control.
LT quantification by capture ELISA. Determination of LT concentrations in
whole-cell extracts was carried out by the capture ELISA method as described
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previously (24). Briefly, microtiter plates (Nunc Maxisorp; Nalge Nunc, Rosk-
ilde, Denmark) were coated with 100 l/well of rabbit anti-CT serum diluted in
PBS (1:1,000), followed by overnight incubation at 4°C. The plates were washed
twice with PBS containing 0.05% Tween 20 (PBS-T) and blocked by incubation
with 5% skim milk in PBS-T for 1 h at 37°C. After additional washings, 100 l of
crude extract and serially twofold-diluted samples were added to the wells and
incubated for 2 h at room temperature. After the plates were washed, mouse
anti-LT serum diluted in PBS-T (1:5,000) was added to the wells and incubated
for 90 min. Detection of bound antibodies was carried out with 100 l of
PBS-T-diluted (1:3,000) horseradish peroxidase-conjugated antimouse-immuno-
globulin G (Sigma-Aldrich, Poole, United Kingdom) incubated for 90 min at
room temperature. After a final washing step, color reactions were developed
with o-phenylenediamine and H2O2. After 20 min at room temperature, the
reactions were interrupted by the addition of 2 M H2SO4 (50 l/well), and the
optical density at 492 nm was measured in a microplate reader (Multiskan EX;
ThermoLabsystems). The final reaction values were obtained after deduction of
background absorbance measured in control wells filled with cell extracts of an
LT-negative derivative of the 4611-4 strain.
Determination of in the vitro cytotonic activity of the LT. The adrenal Y-1 cell
line was cultivated at 37°C to 5  104 cells/well, and 100 l of serial twofold
dilutions of the bacterial filtrates obtained by sonic disruption or purified toxins,
at concentration from 75 g ml1, were inoculated into a microtiter plate for cell
assays, as described previously (23). The microtiter plates were incubated at 37°C
in a 5% CO2 atmosphere and examined daily for the characteristic LT effect. The
TABLE 1. Serotypes and relevant phenotypic features of ETEC strains analyzed in the present study
ETEC strain Serotype Toxin type Sourcea Originb Reference
PE0215 O7:H18 LT-I AC Brazil (northeast) Laboratory collection
121-I O48:H21 LT-I AC Brazil (southeast) 34
4101-1 O114:H LT-I DC Brazil (southeast) 12
PE0534 O106:H40 LT-I AC Brazil (northeast) Laboratory collection
225-IV O148:H28 LT-I AC Brazil (southeast) 34
PE0415 O152:H2 LT-I AC Brazil (northeast) Laboratory collection
4702-1 O67:H5 LT-I AC Brazil (southeast) 12
1372-1 O23:H28 LT-I AC Brazil (southeast) 12
214-III Ont:Hnt LT-I AC Brazil (southeast) 34
4692-1 Ont:H LT-I AC Brazil (southeast) 12
4321-1 Ont:H LT-I DC Brazil (southeast) 12
PE0690 Ont:H8 LT-I AC Brazil (northeast) Laboratory collection
PE0615 Ont:H9 LT-I DC Brazil (northeast) Laboratory collection
4092-7 Ont:H21 LT-I AC Brazil (southeast) 12
PE0260 O8:H9 LT-I DC Brazil (northeast) Laboratory collection
PE0262 O8:H9 LT-I DC Brazil (northeast) Laboratory collection
136-II O88:H25 LT-I AC Brazil (southeast) 34
136-I O88:H25 LT-I AC Brazil (southeast) 34
136-III O88:H25 LT-I AC Brazil (southeast) 34
PE0323 O159:H4 LT-I AC Brazil (southeast) Laboratory collection
63-V O159:H17 LT-I AC Brazil (southeast) 34
4652-2 O159:H34 LT-I AC Brazil (southeast) 12
36-IV O159:H21 LT-I AC Brazil (southeast) 34
187-V O159:H21 LT-I AC Brazil (southeast) 34
36-III O159:H21 LT-I AC Brazil (southeast) 34
H10407 O78:H11 LT-I/ST DC Bangladesh 9
258909-3 O128:H LT-I/ST DC Bangladesh 13
3981-3 O23:H16 LT-I/ST DC Brazil (southeast) 12
0781-3 O23:H16 LT-I/ST DC Brazil (southeast) 12
373F/2 O23:H33/45 LT-I/ST DC Brazil (southeast) 15
25A-1 O78:H12 LT-I/ST DC Brazil (southeast) 15
61A-4 O78:H12 LT-I/ST DC Brazil (southeast) 15
2781-5 O78:H12 LT-I/ST DC Brazil (southeast) 12
PE0347 O78:H12 LT-I/ST AC Brazil (northeast) Laboratory collection
PE0351 O78:H12 LT-I/ST DC Brazil (northeast) Laboratory collection
PE0379 O78:H12 LT-I/ST DC Brazil (northeast) Laboratory collection
38A-4 O6:H16 LT-I/ST DC Brazil (southeast) 15
1111-1 O6:H16 LT-I/ST DC Brazil (southeast) 12
C13/4 O6:H16 LT-I/ST DC Brazil (southeast) 15
4372-4 O6:H16 LT-I/ST AC Brazil (southeast) 12
4021-5 O6:H16 LT-I/ST DC Brazil (southeast) 12
TR298/1 O6:H16 LT-I/ST DC Brazil (southeast) 35
TR274 O6:H16 LT-I/ST DC Brazil (southeast) 35
TR131 O6:H16 LT-I/ST DC Brazil (southeast) 35
1661-1 O6:H16 LT-I/ST DC Brazil (southeast) 12
4261-2 O6:H16 LT-I/ST DC Brazil (southeast) 12
PE0016 O6:H16 LT-I/ST DC Brazil (northeast) Laboratory collection
PE0064 O6:H16 LT-I/ST AC Brazil (northeast) Laboratory collection
4441-1 O6:H16 LT-I/ST DC Brazil (southeast) 12
4291-1 O6:H16 LT-I/ST DC Brazil (southeast) 12
4292-1 O6:H16 LT-I/ST AC Brazil (southeast) 12
a AC, asymptomatic child; DC, diarrheic child.
b Northeast, samples isolated from Pernambuco State (northeastern region of Brazil); southeast, samples isolated from Sa˜o Paulo or Rio de Janeiro State
(southeastern region of Brazil).
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endpoint was taken as the highest dilution of the sample that changed 50% of the
Y-1 cell morphology after incubation. Each sample was tested at least in tripli-
cate, and the results were analyzed by phase-contrast microscopy.
Rabbit ligated ileal loop assay. Tests in rabbit ligated ileal loops were per-
formed as previously described (24) with approximately1.5-kg male New Zealand
White rabbits. The rabbits were fasted for 48 h prior to surgery, except for
ingestion of water with glucose. Laparotomy was carried out aseptically to ex-
ternalize the intestines of the animals, which were kept under anesthesia by intra-
muscular administration of telazol (20 mg kg of body weight1) and nilperidol (0.1
mg kg1). Isolated 5-cm duodenum loops were spaced by 2-cm interposing loops
with ligatures. Whole-cell extracts, generated after sonic disruption of the bac-
terial cells, or purified protein samples containing the same amount of toxin (150
ng) were injected into each tied ileal loop, followed by intestine internalization
and incision closure. The volumes of accumulated fluids in each loop were
measured 18 h after the inoculation of the bacterial strains. A plasmid-cured
LT strain (strain 4611-4) was employed as a negative control. All strains were
cultivated in CAYE broth overnight before sonic disruption.
Nucleotid sequence accession numbers. The complete nucleotide sequences of
the elt operons of 14 LT types out of the 16 studied were submitted to GenBank
and were given the following accession numbers: EU113242 (LT3), EU113243
(LT4), EU113244 (LT5), EU113245 (LT6), EU113246 (LT7), EU113247 (LT8),
EU113248 (LT9), EU113249 (LT10), EU113250 (LT11), EU113251 (LT12),
EU113252 (LT13), EU113253 (LT14), EU113254 (LT15), and EU113255
(LT16).
RESULTS
RFLP analysis of the elt operons from human-derived ETEC
strains. Amplification of the elt operon yielded a 1,257-bp
fragment common to all 51 tested ETEC strains, including 25
strains producing LT only, 25 LT/ST strains, and the refer-
ence LT/ST H10407 strain. Restriction of the amplified
fragment was carried out with nine restriction enzymes (BsaI,
DdeI, HhaI, HincII, HinfI, HphI, TacI, MspI, and NdeI) with
cleavage sites found in the reported sequence of the H10407 elt
operon. Polymorphic band profiles were detected with six en-
zymes (BsaI, DdeI, HhaI, HincII, HphI, and MspI), resulting
in seven defined RFLP types named RFLP-I to RFLP-VII.
RFLP-I included the reference H10407 strain and all tested
strains of serotypes O6:H16 (15 strains), O88:H25 (3 strains),
and O8:H9 (2 strains), as well as 5 strains producing LT only
and expressing different serotypes (Table 2). RFLP-II was
found in a single O152:H2 strain (PE0415) in which one BsaI
restriction site was lost concomitantly with the acquisition of a
new DdeI site. RFLP-III was detected in the 4692-1 (Ont:H [nt
indicates not typeable by conventional methods]) strain and con-
sisted of the simultaneous acquisition of a new MspI restriction
site and the loss of another site for the same restriction enzyme at
the eltA and eltB cistrons, respectively. RFLP-IV encompassed six
LT ETEC strains belonging to serotypes O159:H34 (4652-2),
O23:H16 (0781-3 and 3981-3), O23:H33/45 (373F/2), Ont:Hnt
(214-III), and O7:H18 (PE0215) and consisted of the loss one of
two HincII restriction sites in the eltA cistron. RFLP-V included
all tested O159:H21 (three) and O78:H12 (six) strains, the
258909-3 strain, and three ETEC strains producing LT only be-
TABLE 2. RFLP patterns of the elt operons detected among the ETEC strains studied
PCR-RFLP typea ETEC serotype (strain)b Nucleotide alterationc LT typed
I O78:H11 (H10407) LT1
O114:H (4101-1) LT1
O8:H9 (PE0260, PE0262) LT1
O6:H16 (15 strains) LT1
O88:H25 (136-I, 136-II, 136-III) LT3/LT5
O48:H21 (121-I) LT5
O167:H5 (4702-1) LT9
Ont:H (4321-1) LT12
Ont:H9 (PE0615) LT13
II (BsaI-/DdeI) O152:H2 (PE0415) BsaI, nt 661 of eltA (A to G) LT8
DdeI, nt 842 of eltA/B (C to T)
III (MspI-/MspI) Ont:H (4692-1) Msp, nt 93 of eltA (A to G) LT11
Msp, nt 995 of eltB (G to T)
IV (HincII) O159:H34 (4652-2) Nt 747 of eltA (C to T) LT1
O23:H16 (0781-3) LT1
O7:H18 (PE0215) LT1
O23:H16 (3981-3) LT1
O23:H33/45 (373F/2) LT1
Ont:Hnt (214-III) LT10
V (HphI) O128:H (258909-3) Nt 641 of eltA (G to A) LT2
O159:H4 (PE0323) LT2
O159:H21 (3 strains) LT2
O106:H40 (PE0534) LT7
O159:H17 (63-V) LT14
O78:H12 (6 strains) LT2/LT15/LT16
VI (HhaI) O23:H28 (1372-1) Nt 973 of eltB (C to A) LT4
O148:H28 (225-IV) LT6
VII (HphI/HhaI) Ont:H8 (PE0690) HphI, nt 641 of eltA (G to A) LT2
Ont:H21 (4092-7) HhaI, nt 971 of eltB (C to T)
a PCR-RFLP patterns detected among the 51 ETEC strains analyzed. Restriction enzymes revealing the distinct RFLP types are indicated in parentheses. RFLP-II
and -III types involve the concomitant loss of one restriction site and the acquisition of another one. The RFLP-VII type involves the concomitant loss of two restriction
sites.
b ETEC serotypes and strains sharing the same PCR-RFLP type. Specific tested strains are indicated in parentheses.
c Specific nucleotide changes at the elt operon (1,257 bp) leading to the altered PCR-RFLP patterns. Nucleotide (nt) 1 encompasses the first structural codon of the
elt operon. All changes were based on the nucleotide sequence of the H10407 elt operon (PCR-RFLP type I).
d LT types, defined by specific amino acid replacements, in each RFLP type.
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longing to different serotypes and involved the loss of the unique
HphI restriction site (Table 2). RFLP-VI was characterized by the
lost of the single HhaI restriction site in the eltB coding region.
This RFLP type was shared by two human-derived LT ETEC
strains belonging to different serotypes (O148:H28 [225-IV] and
O23:H28 [1372-1]) (Fig. 1 and Table 2). Notably, the same RFLP
type has been proposed to differentiate LTs produced by ETEC
strains isolated from pigs (LTp) from those isolated from humans
(45). The last RFLP group (RFLP-VII) included two LT ETEC
strains (4092-7 and PE0690) in which the polymorphic band pro-
files resulted from loss of both HhaI and HphI restriction sites of
the elt amplicon.
Single-nucleotide polymorphism analysis of the elt operon.
The previous RFLP analyses indicated that a considerable
genetic diversity existed among the elt operons carried by the
tested ETEC strains, particularly among strains producing LT
only. To further evaluate the extent of the genetic diversity of
the LT-encoding genes, we sequenced LT-encoding regions of
the elt operons of 51 ETEC strains, including the H10407
and the 258909-3 strains, originally isolated from patients in
Bangladesh (9, 13). Taken together, the sequence analysis re-
vealed 50 base changes at 48 different polymorphic sites in the
elt operon. Thirty-four polymorphic sites were located in eltA,
including 4 sites in the sequence encoding the signal peptide,
17 sites in the sequence encoding the A1 subunit, and 13 sites
in the sequence encoding the A2 subunit. The eltB cistron
showed 16 polymorphic sites, including 5 sites in the sequence
encoding the signal peptide and 11 sites in the structural gene.
Thirty polymorphic sites resulted in changes in the amino acid
sequences, including 21 amino acid changes in eltA and 9 in
eltB (Fig. 2). The replacement of asparagin by aspartic acid in
position 238 was observed only in the elt operon of H10407 and
thus was not considered for the definition of an additional LT
type. Of the remaining 20 polymorphic sites in LTA, 2 were
located in the signal peptide (F-10V and F-10A), 10 in the A1
subunit (K4R, Y6C, P12S, D14Y, R18H, M23I, M37I, D160G,
Q185R, and S190L), and 8 in the A2 subunit (T193A, G196D,
T203A, K213E, S224T, I232M, N234S, and R235G). In the
LTB subunit, four polymorphic sites were located in the signal
peptide (C-16F, A-10V, C-4Y, and Y-2H) and five sites in the
mature protein amino acid sequence (S4T, R13H, A46E,
T75A, and E102K). In Fig. 2, the positions of the detected
polymorphic sites are indicated in the structures of LT sub-
units, except two sites in the A1 subunit (Q185R and S190L)
and one in the A2 subunit (T193A) located in loops with
unresolved structures.
Based on the sequence analysis of the elt operon, 16 LT
types were detected with regard to the elt sequence of the
reference H10407 strain. The polymorphic site at position 238
was not considered for definition of LT types, since it was
restricted to the H10407 strain. As indicated in Table 3, the
most frequently found LT type (LT1) was shared by 24 of the
51 tested ETEC strains, including the reference H10407 strain
and all tested O6:H16 strains. The second most frequently
expressed LT type (LT2) was characterized by four polymor-
phic sites in the A subunit (S190L, G196D, K213E, and S224T)
and one polymorphic site in the B subunit (T75A). This LT
type seems to have a widespread distribution; it was detected
among both LT and LT/ST strains and in an ETEC strain
(258909-3) derived from a subject in Bangladesh. This LT
allele was also independently reported 10 years ago in a Jap-
anese tourist returning from Israel (20). LT3, displayed by two
O88:H25 strains, showed two polymorphic sites in the A sub-
unit (K213E and R235G), while LT4 showed the same amino
acid sequence as the previously described LTp (20, 50) with
two polymorphic sites (K4R and K213E) in the A and three
polymorphic sites (S4T, A46E, and E102K) in the B subunit.
The remaining 12 LT types differ from LTs produced by the
H10407 strain by the presence of from one (such as the LT9
and LT12 types) to six (such as the LT7 and LT14 types)
polymorphic sites (Table 3). In total, six different LT types
(LT1, LT3, LT5, LT9, LT12, and LT13) were grouped in the
RFLP-I group, five (LT2, LT7, LT14, LT15, and LT16) in
RFLP-V, and two (LT1 and LT10) in RFLP-IV, reflecting the
higher discriminatory power of the sequencing analysis with
regard to RFLP typing (Table 2). Similarly, RFLP-VI, previ-
ously recognized as indicative of LTp, encompassed two LT
types (LT4 and LT6). The remaining RFLP types encom-
passed a single LT type each (Table 2).
The LT polymorphism observed among the tested ETEC
strains showed that some of the natural variants are related. To
illustrate the similarity relationships of the LT variants de-
tected in the present study, the amino acids of the complete
structural sequences of the two subunits were aligned and an
unrooted phylogram was constructed based on the neighbor-
joining algorithm (Fig. 3). The 16 LT types were clustered in
four major groups with six (LT1, LT9, LT10, LT12, LT13, and
the most distantly related, LT11), two (LT4 and LT6), three
(LT3, LT5, and LT8), and five (LT2, LT7, LT14, LT15, and
LT16) members, referred to as A, B, C, and D, respectively.
Notably, the most frequently found LT types, LT1 and LT2,
were clustered in the two most distantly related groups, while
group C encompassed LT types sharing complete identity or
close similarity to the previously described LTp (Fig. 3).
Clonally distinct ETEC strains may express the same LT
type. Our previous analyses have demonstrated that ETEC
strains sharing the same serotype and virulence-associated fac-
FIG. 1. PCR-RFLP patterns of the elt operons derived from dif-
ferent ETEC strains. Lane M, 100-bp molecular-size ladder (Invitro-
gen); lane A, elt operon amplified from the H10407 strain. PCR prod-
ucts digested with HhaI, BsaI, DdeI, HincII, MspI, and HphI are
indicated. Lanes 1, elt operons amplified from the reference strain
H10407 treated with the indicated restriction endonuclease; lanes 2, elt
operons amplified from polymorphic ETEC strains treated with the
indicated restriction endonuclease (HhaI, strain 1372-1; BsaI, strain
PE0415; DdeI, strain PE0415; MspI, strain 4692-1; HincII, strain
4652-2; and HphI, strain 36-III).
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tors may be clonally related, as demonstrated by RAPD anal-
ysis (29, 31, 32). In order to evaluate whether ETEC strains
sharing a specific LT type were clonally related, we determined
the RAPD band profiles of strains expressing either the LT1,
LT2, or LT3 type (Fig. 4). Indeed, ETEC strains of serotype
O6:H16 (15 strains), O78:H12 (6 strains), and O88:H25 (2
strains) belonged to different clonal groups and expressed dif-
ferent LT types (LT1, LT2, and LT3, respectively). On the
other hand, O78:H11, O8:H9, O6:H16, O7:H18. and O114:H
ETEC strains belong to different clonal groups but share the
same LT type (LT1). These results indicate that, based on the
strain set analyzed, clonally distinct ETEC strains may share
the same LT allele, suggesting lateral transfer of the elt operon
among clonally unrelated strains.
Functional characterization of LT variants expressed by
ETEC strains. Although the observed polymorphism of LT
expressed by human-derived ETEC strains did not involve
amino acid residues known to participate directly either in
ADP ribosylation or GM1 receptor binding, conformational
changes may indirectly affect the biological activities of variant
LT types with regard to the reference LT derived from the
H10407 strain. Based on the widespread occurrence of the
polymorphic sites and their close proximity to amino acids
residues known to affect the activity or stability of the toxin, we
selected seven LT types (LT1, LT2, LT4, LT5, LT9, LT13, and
LT16) to be tested, either as purified toxins (LT1, LT2, and
LT4) or as sonically disrupted whole-cell extracts, both in vitro,
by means of the cytotonic effect on cultured Y-1 cells, and in
vivo, based on fluid accumulation in rabbit ligated ileal loops.
LT1, LT4, LT5, and LT2 were representative of the A, B, C,
and D groups. On the other hand, LT9, LT13, and LT16 were
tested due to the close proximity of the polymorphic site to the
Arg7 residue, previously shown to dramatically affect the ADP-
ribosyltransferase activity of the toxin (26a). Polyacrylamide
gel analyses of the three toxins purified by galactose affinity
chromatography showed that all detected B subunits were as-
sembled into stable pentamers in unboiled samples (Fig. 5).
Additionally, densitometric analysis of stained gels indicated
that all three toxins presented similar A and B subunit distri-
bution ratios (1:5) (Fig. 5 and data not shown). In vitro analysis
FIG. 2. LT structural model with locations of the polymorphic sites detected in the present study. The LT structural coordinates were retrieved from
the PDB (code 1LTS). (A) Structural model of the whole toxin (A and B subunits). (B) Structural model of the A1 subunit with positions (arrows) of
nine polymorphic sites with amino acid residues present in the available PDB file. (C) Structural model of the A2 subunit with positions (arrows) of seven
polymorphic sites with amino acid residues present in the available PDB file. (D) Structural model of the B subunit with positions (arrows) of the five
polymorphic sites with amino acid residues present in the available PDB file. Polymorphic sites are shaded dark. Three polymorphic sites (Q185R, S190L,
and T193A) were located on a loop encompassing the disulfide bridge linking A1 and A2 subunits, which has not been structurally solved in the PDB
file.
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of the purified LT1, LT2, and LT4 showed no significant dif-
ference with regard to binding affinity to the ganglioside in
competitive GM1-binding assays (Fig. 5). Nonetheless, the
toxic effects of LT4 proved to be significantly less than those
detected with LT1, LT2, LT5, LT9, LT13, and LT16, either
with the purified proteins or with whole-cell extracts, both in
vitro with Y-1 cells and in vivo with fluid accumulation in the
rabbit ligated ileal loop assays (Table 4). These results indicate
that LT4, which is identical to the previously described LTp,
has reduced toxicity to eukaryotic cells, while the other tested
LT variants showed behavior similar to that of the reference
toxin produced by the H10407 ETEC strain.
DISCUSSION
The present report is the first systematic study of the natural
genetic diversity of LT-Is produced by ETEC strains isolated
from humans. Based on a set of 51 strains, we detected a rather
high variability of LT, which was disclosed by RFLP and DNA-
sequencing methods. The detected polymorphism represents a
considerable increase in the available knowledge of the diver-
sity of the elt operon. Indeed, six out of the seven RFLP types
and 16 of the 31 reported polymorphic sites are described for
the first time and clearly demonstrate that the natural diversity
of LTs produced by human-derived ETEC strains has been
underestimated during recent decades. Moreover, the re-
stricted number of strains tested and the fact that most of them
were isolated in Brazil suggest that LT diversity, as well as the
possible impacts of such diversity on the epidemiology of the
ETEC-associated disease, remains underestimated on a world-
wide scale.
The detection of high natural diversity of LTs in a rather
small set of ETEC strains may be ascribed to two major facts.
First, we carried out a systematic analysis of LT genetic diver-
sity, employing two powerful molecular typing methods (RFLP
TABLE 3. Deduced amino acid compositions of variant A and B
subunits obtained from sequenced elt operons of all ETEC strains
analyzed in this study
LT allelic
type
ETEC strain serotype
(no. of samples)
Positions of the mutated amino
acids in subunit:
A B
LT1 H10407 (O78:H11)a
O6:H16 (15)
O8:H9 (2)
O7:H18 (1)
O114:H (1)
O23:H16 (2)
O23:H33/H45 (1)
O159:H34 (1)
LT2 O78:H12 (4) S190L, G196D, K213E,
S224T
T75A
O159:H21 (3)
O128:H (1)
Ont:H8 (1)
Ont:H21 (1)
O159:H4 (1)
LT3 O88:H25 (2) K213E, R235G
LT4 O23:H28 (1) K4R, K213E S4T, A46E,
E102K
LT5 O48:H21 (1) K213E, R235G R13H
O88:H25 (1)
LT6 O148:H28 (1) K4R, K213E S4T, A46E
LT7 O106:H40 (1) P12S, S190L, G196D,
K213E, S224T
T75A
LT8 O152:H2 (1) T203A, K213E R13H
LT9 O167:H5 (1) D14Y
LT10 Ont:Hnt (1) Q185R, N234S
LT11 Ont:H (1) M37I, T193A, K213E,
I232M
LT12 Ont:H (1) M37I
LT13 Ont:H9 (1) R18H, M23I
LT14 O159:H17 (1) D160G, S190L, G196D,
K213E, S224T
T75A
LT15 O78:H12 (1) S190L, K213E T75A
LT16 O78:H12 (1) Y6C, S190L, G196D,
K213E
T75A
a Based on the corrected amino acid sequence of the LT encoded by strain
H10407 (6). The polymorphic site at position 238 (N238D) found in the elt
operon of strain H10407 was not considered for the definition of a new LT type.
FIG. 3. Unrooted phylogram constructed by the neighbor-joining
method showing the sequence relationships of the concatenated amino
acid sequences of the mature A and B subunits of the detected LT
variants.
FIG. 4. RAPD profiles of representative ETEC strains expressing
the prevailing LT types reported in this study. RAPD profiles were
obtained by amplification of genomic DNA with the 1254 primer. LT1,
RAPD profiles of ETEC strains sharing the LT1 type: lane 1, reference
strain H10407 (O78:H11); lane 2, strain PE0260 (O8:H9); lane 3,
strain 4291-1 (O6:H16); lane 4, strain 4292-1 (O6:H16); lane 5, strain
PE0215 (O7:H18); lane 6, strain 4101-1 (O114:H). LT2, RAPD pro-
files of ETEC strains sharing the LT2 type: lane 7, strain PE0347
(O78:H12); lane 8, strain PE0379 (O78:H12); lane 9, strain 25A-1
(O78:H12); lane 10, strain 2781-5 (O78:H12). LT3, RAPD profiles of
ETEC strains sharing the LT3 type: lane 11, strain 136-I (O88:H25);
lane 12, strain 136-II (O88:H25). Lane M, 100-bp molecular-size lad-
der (Invitrogen). The arrows indicate the positions of 500 (bottom)
and 2,072 (top) bp.
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and DNA sequencing). Second, the nature of the selected
strain set was designed to encompass ETEC strains previously
shown to be genetically heterogeneous, as inferred from their
serotypes (20 different serotypes and six nontypeable strains)
and toxinogenic profiles. Half (25 strains) of the tested strains
were strains producing LT only, usually recognized by their
heterogeneous nature, lack of an identifiable CF, and frequent
recovery from asymptomatic subjects (33). Indeed, among the
25 tested LT ETEC strains, we found all seven detected
RFLP types and 14 of the 16 LT sequence types. On the other
hand, LTs encoded by 26 LT/ST ETEC strains were classi-
fied in three RFLP types and four LT types. These results
suggest that LTs produced by LT-only ETEC strains, particu-
larly among strains isolated from asymptomatic subjects, are
more genetically variable than LTs produced by LT/ST
strains. This finding raises interesting questions concerning the
high incidence of ETEC strains producing only LT among
nondiarrheic children in epidemiological studies carried out in
different regions of endemicity (32). Additionally, such findings
might indicate that in areas of endemicity, ETEC strains pro-
ducing LT only are subject to selective forces, leading to a
more diverse repertoire of LT sequences that could contribute
to immunological escape mechanisms. Future studies aimed at
the determination of LT types produced by ETEC strains iso-
lated from different geographical regions should shed more
light on the relevance of LT typing and the epidemiology of
ETEC-associated disease. RFLP typing has been the only
method employed for many years to differentiate LTh and LTp
(25, 45, 47). Although restricted, such differentiation was the
most convincing demonstration of the natural diversity of
LT-Is produced by wild-type ETEC strains. In the present
study, seven RFLP types were identified among the 51 ETEC
strains, including the HhaI polymorphism at the eltB cistron,
previously employed to differentiate LTh and LTp, and a new
HhaI HphI polymorphism in which the loss of the HhaI site
was due to a distinct base replacement. The finding of six new
polymorphic sites in the elt operon reinforces the use of such
molecular typing methods as simple and fast tools to disclose
LT variants produced by wild-type ETEC strains isolated from
humans or other vertebrate hosts. On the other hand, our
results demonstrate that ascribing a specific RFLP type to an
ETEC group, such as those derived from different mammalian
hosts or based on strains sharing a specific serotype or viru-
lence-associated markers, may not disclose the real LT diver-
sity, as demonstrated by RFLP types I, IV, V, and VI, which
encompass two to six different LT types identified by DNA
sequencing. The lower resolution of the RFLP analysis is
clearly demonstrated by the artificial differentiation of LTp
and LTh. Among the four ETEC strains sharing the loss of the
HhaI restriction site, three were genetically distinct and be-
longed to different LT types.
The location of the elt operon in high-molecular-weight plas-
mids and the frequent finding of flanking palindromic se-
quences strongly suggest that lateral gene transfer mechanisms
contributed to the dissemination of the LT-encoding genes
among wild-type ETEC strains (37, 39, 49). The dynamic na-
FIG. 5. Purification of three LT types and competitive binding assays carried out with the GM1 ganglioside. (A) Representatives of LT1, LT2,
and LT4 purified by galactose affinity chromatography and sorted in a Coomassie blue-stained polyacrylamide gel. Samples of purified toxins were
applied in the polyacrylamide gels before (lanes 1 to 3) or after (lanes 4 to 6) 5 min of boiling. The samples of purified LT were as follows: LT1,
lanes 1 and 4; LT2, lanes 2 and 5; and LT4, lanes 3 and 6. (B) GM1-binding curves of different LT variants determined in competitive ELISA with
peroxidase-labeled CT. Shown are Scatchard plots for the binding of wild-type LT (LT1), LT from ETEC 25A-1 (LT2), LT from ETEC 1372-1
(LT4), and CT. The data are means  standard deviations of duplicate samples and are representative of three independent experiments.
TABLE 4. Toxic activities of different LT types measured both in
vitro, by the cytotonic action on cultivated Y-1 cells, and
in vivo, by fluid accumulation in rabbit ligated ileal loops
LT typea
Cytotonic effect
on Y-1 cells
(ng ml1)b
Fluid accumulation in
rabbit ligated ileal
loop (ml 5 cm1)c
Purified toxins
LT1 (H10407) 3.5  2.0 10.0  0.5
LT2 (25A-1) 1.64  0.6 12.75  3.18
LT4 (1372-1) 65.65  18.75 0.5
Cell lysates
LT (4611-4)d 0.5
LT1 (H10407) 0.89  0.43 6.0  3.0
LT2 (25A-1) 0.62  0.41 12.5  1.5
LT4 (1372-1) 15.67  5.43 0.5
LT5 (136-III) 0.29  0.05 11.5  3.54
LT9 (4702-1) 0.59  0.08 7.85  1.63
LT13 (PE0615) 0.29  0.07 10.53  0.92
LT16 (2781-5) 0.44  0.2 9.75  2.47
a Different LT types, as either purified toxins or sonically disrupted whole-cell
extracts. The LT-producing ETEC strains are indicated in parentheses.
b The values indicate the concentrations of LT that induced visible cytotonic
effects in 50% of the Y-1 cells examined. The concentrations of LT were deter-
mined by capture ELISA using LT-specific antibodies, as described in Materials
and Methods.
c Volume (ml) of liquid accumulated in rabbit ligated ileal loops following
inoculation of 150 ng of toxin, either purified or in whole-cell extracts.
d LT ETEC strain.
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ture of ETEC-associated genes has been confirmed by multilo-
cus sequence-typing analyses of clonally distinct E. coli strains
(43). Indeed, the acquisition of enterotoxin genes may be suf-
ficient to generate an ETEC strain, which may belong to many
phylogenetically distinct lineages. In the present study, we
identified 16 LT types, taking into account 31 amino acid
replacements with regard to the toxin encoded by the reference
H10407 strain. These results further demonstrate the dynamic
nature of the elt operon based on the widespread distribution
of two LT types (LT1 and LT2), which are shared by clonally
unrelated ETEC strains, as demonstrated by RAPD analysis.
The same conclusion may be drawn with strains sharing the
same phenotypic and genotypic profiles but expressing differ-
ent LT types, as illustrated by the O88:H25 and O78:H12
strains. On the other hand, we observed some close relation-
ships between some LT types and the phenotypic and geno-
typic features of certain ETEC groups. For example, all tested
O6:H16 (16) and O78:H12 (4) strains carried the same LT
types, LT1 and LT2, respectively. Taken together, the present
observations show that much still has to be done in order to
achieve a better understanding of the dynamics of the elt
operon transfer among wild-type ETEC strains with similar or
different phenotypic traits and genetic compositions.
The LT2 type, characterized by four mutations in the A
subunit (S190L, G196D, K213E, and S224T) and one mutation
in the B subunit (T75A), was shown to be the second most
widely distributed LT type among wild-type ETEC strains.
This LT type was detected in six different serotypes and was
recovered from subjects in different regions in Brazil and Ban-
gladesh (represented by the 258909-3 strain). The same LT has
also been detected in an ETEC strain isolated from a Japanese
tourist, further demonstrating the distribution of the type on a
worldwide scale (20). Interestingly, the same group reported
that, in contrast to other ETEC strains, the gene encoding this
variant LT was integrated into the chromosomal DNA of the
strain (20). In our strains, preliminary data indicated that, at
least in some strains, the elt operon encoding the LT2 type is
located on episomal plasmids, but further analyses should eval-
uate in more detail the locations of the replicons encoding
different LT types.
The close proximity of the reported sequences of the LT
types allowed us to establish putative evolutionary relation-
ships among them, which resulted in the definition of four
major similarity groups. The close proximity of the LT variant
amino acid sequences, which differ in a maximum of seven
residues, restrict precise phylogenetic inferences but suggest
that the two most widely distributed LT types (LT1 and LT2)
are representative of two divergent LT groups, while the third
and fourth groups (B and C) represent different groups en-
compassing LT4 (LTp) and the closely related LT6 type (group
B), as well as LT3, LT5, and LT8 in a fourth group (C). These
data led us to conclude that the differentiation of LTh and LTp
is artificial and should be reconsidered based on a more de-
tailed analysis of the natural diversity of LTs produced by
ETEC strains isolated from different mammalian hosts. Thus,
the finding of an LT4-producing ETEC strain in a human host
would not necessarily be indicative of a zoonotic infection. On
the other hand, the definition of four LT groups based on
sequence similarity suggests that the LT variants are subject to
evolutionary forces that may affect biochemical and biological
features of the toxins encoded by different ETEC strains. In-
deed, a clear correlation between genetic diversity and altered
biological functions has already been established for Shiga-like
toxin (Stx) variants produced by enterohemorragic E. coli
strains (8, 41).
In our initial characterization of the biological functions
of natural LT variants expressed by wild-type ETEC strains,
toxins representing seven LT types were selected for in vitro
and in vivo testing with either purified toxins (LT1, LT2, and
LT4) or whole-cell extracts. The purified toxins revealed no
significant difference with regard to receptor (GM1) binding
affinity, but a probe of the toxic effects of the LT variants
indicated that LT4, which is identical to the previously re-
ported LTp, has reduced cytotonic effects on Y-1 cells and
did not lead to fluid accumulation in rabbit ligated ileal
loops. Previous evidence, based on whole-cell lysates or
culture supernatants, indicated that LTp has toxic effects,
including the activation of adenylate cyclase, similar to the
toxin produced by the human-derived ETEC strains (22). In
contrast to such results, the purified LT4, as well as whole
bacterial lysate of the wild-type ETEC strain, showed re-
duced toxic effects under in vitro and in vivo conditions. The
purified toxin was also evaluated for purity, the presence of
an altered A and B ratio distribution, and susceptibility to
protease attack without any evidence for altered behavior
with regard to other tested LT variants (unpublished obser-
vation). Indeed, the closely related LT6 type also showed
reduced toxicity when tested with Y-1 cells and whole bac-
terial lysates, suggesting that replacement of lysine by argi-
nine at position 4 of the A1 subunit affects the biological
activities of these LT variants (unpublished observations).
The close proximity of this polymorphic site to the arginine
residue at position 7 suggests that the K4R substitution
would change the structural organization of the toxin active
site in a fashion similar to that of the R7K mutant generated
by site-directed mutagenesis (44). Further functional char-
acterization of LT4, together with biochemical and struc-
tural analyses, is currently under investigation and will help
us to evaluate the impact of this polymorphism on the ac-
tivities of LTs produced by these wild-type ETEC strains.
As recently demonstrated by us, wild-type ETEC strains
may differ in the amounts of LT produced and/or secreted
under in vitro and in vivo growth conditions (24). Indeed,
the inherent variability of ETEC strains in secreting LTs
may correlate with the incidence and severity of diarrheal
episodes in either humans or other mammalian hosts (2, 4,
40). The findings that LTs produced by ETEC strains iso-
lated from humans show considerable genetic diversity add
a further aspect to be evaluated concerning the contribution
of these features to the complex epidemiology of the disease
and may contribute to the design and development of more
rational prophylactic and therapeutic approaches against
ETEC-associated diarrhea.
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